Additional information
Yellow Powder
NA
ACI-020811
287.3-288.4°C
C11H13Cl2N5O2
318.16
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
6-(2-imidazoline-2-ylidineamino)- 1,2,3,4-tetrahydroquinoxalin-2,3-dione dihydrochloride
6-(2-imidazoline-2-ylidineamino)- 1,2,3,4-tetrahydroquinoxalin-2,3-dione dihydrochloride
6-[(4,5-dihydro-1H-imidazol-2-yl)amino]-1,4-dihydro-2,3-quinoxalinedione